Table 5.
Treatments1 | ||||||
---|---|---|---|---|---|---|
CON | SB | MCFA | n-3 PUFA | SEM | P-value | |
Total protein, g/L | 56.1b | 66.7a | 57.7b | 58.9b | 1.16 | <0.001 |
Glucose, mmol/L | 2.24b | 2.56b | 3.49a | 2.31b | 0.12 | 0.020 |
Plasma urinary nitrogen, mmol/L | 2.20b | 2.91a | 3.17a | 2.84a | 0.10 | <0.001 |
Glutamic oxaloacetic transaminase, U/L | 69.0a | 68.4a | 46.8b | 64.3a | 3.03 | <0.001 |
Glutamic pyruvic transaminase, U/L | 44.0b | 39.6b | 63.9a | 43.7b | 2.26 | <0.001 |
Alkaline phosphatase, U/L | 411d | 594c | 734a | 689b | 13.1 | <0.001 |
Triglycerides, mmol/L | 0.64b | 0.71a | 0.37c | 0.34c | 0.02 | <0.001 |
Free fatty acids, μmol/L | 200d | 283c | 450b | 855a | 17.9 | <0.001 |
Cholesterol, mmol/L | 4.22a | 3.15b | 2.37c | 1.79d | 0.09 | <0.001 |
High-density lipoprotein, mmol/L | 1.14c | 1.80a | 2.11a | 1.36b | 0.06 | <0.001 |
Low-density lipoprotein, mmol/L | 0.88 | 0.90 | 0.96 | 0.98 | 0.03 | 0.060 |
Very low-density lipoprotein, mmol/L | 0.87 | 0.90 | 1.05 | 0.88 | 0.02 | 0.081 |
Albumin, g/L | 22.8a | 21.0a | 22.3a | 17.3b | 0.65 | <0.001 |
Globulin, g/L | 33.2b | 45.8a | 35.5b | 41.7a | 1.29 | <0.001 |
Albumin/globulin | 0.70a | 0.46c | 0.63b | 0.42c | 0.03 | <0.001 |
IgA, μg/mL | 8.85b | 12.5a | 9.04b | 10.3ab | 0.72 | <0.001 |
IgG, μg/mL | 43.5c | 91.6a | 69.2b | 90.8a | 3.73 | <0.001 |
IgM, μg/mL | 72.4c | 104a | 84.7b | 78.1bc | 4.60 | 0.002 |
1CON, basal diet; SB, basal diet + 1 g/kg coated sodium butyrate; MCFA, basal diet + 7.75 g/kg coated medium-chain fatty acids; n-3PUFA, basal diet + coated 68.2 g/kg n-3 polyunsaturated fatty acids. Data are presented as mean ± SEM (n = 6).
a–cValues in the same row with different letter superscripts mean significant difference (P < 0.05).